PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-4.70%
Both yoy net incomes decline, with MRVL at -26.06%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-1.96%
Negative yoy D&A while MRVL is 3.10%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
155.56%
Some yoy growth while MRVL is negative at -8547833.33%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-5.33%
Both cut yoy SBC, with MRVL at -8.59%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
131.94%
Slight usage while MRVL is negative at -97.11%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
81.25%
AR growth while MRVL is negative at -39.86%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
70.00%
Inventory shrinking or stable vs. MRVL's 175.80%, indicating lean supply management. David Dodd would confirm no demand shortfall.
52.78%
A yoy AP increase while MRVL is negative at -969.50%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
261.70%
Growth well above MRVL's 223.69%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
833.33%
Lower 'other non-cash' growth vs. MRVL's 11242.12%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
70.77%
Some CFO growth while MRVL is negative at -27.81%. John Neff would note a short-term liquidity lead over the competitor.
-27.84%
Both yoy lines negative, with MRVL at -54.83%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
27.84%
Some acquisitions while MRVL is negative at -122.69%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
58.49%
Some yoy expansion while MRVL is negative at -147.10%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-69.92%
We reduce yoy sales while MRVL is 35.32%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-24.74%
Both yoy lines negative, with MRVL at -2787.61%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-168.39%
Both yoy lines negative, with MRVL at -280.36%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
1.75%
Issuance growth of 1.75% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-1.80%
We cut yoy buybacks while MRVL is 18.91%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.